Global Infectious Diseases Preliminary Screening Tests Market Research Report 2024(Status and Outlook)
Report Overview:
A preliminary screening is a breath or saliva test administered by a law enforcement officer to determine whether an arrest should be made and whether an evidentiary test should be requested. Preliminary screening results may not be used as evidence of impairment in any court proceeding.
The Global Infectious Diseases Preliminary Screening Tests Market Size was estimated at USD 1459.06 million in 2023 and is projected to reach USD 2598.95 million by 2029, exhibiting a CAGR of 10.10% during the forecast period.
This report provides a deep insight into the global Infectious Diseases Preliminary Screening Tests market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Infectious Diseases Preliminary Screening Tests Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Infectious Diseases Preliminary Screening Tests market in any manner.
Global Infectious Diseases Preliminary Screening Tests Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott
BD
Bio-rad Laboratories, Inc
Cepheid
Hologic Inc
Meridian Bioscience, Inc
OraSure Technologies, Inc
Quidel Corporation
F. Hoffmann-La Roche Ltd
BUREAU VERITAS
Eurofins Scientific
Siemens Healthcare Private Limited
Luminex Corporation
PerkinElmer Inc
QIAGEN
Mesa Biotech
Illumina, Inc
Market Segmentation (by Type)
Over-the-Counter Rapid Test Product
Professional Rapid Test Product
Market Segmentation (by Application)
Infectious Diseases
Hepatitis
Influenza
Malaria
HIV
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Infectious Diseases Preliminary Screening Tests Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
A preliminary screening is a breath or saliva test administered by a law enforcement officer to determine whether an arrest should be made and whether an evidentiary test should be requested. Preliminary screening results may not be used as evidence of impairment in any court proceeding.
The Global Infectious Diseases Preliminary Screening Tests Market Size was estimated at USD 1459.06 million in 2023 and is projected to reach USD 2598.95 million by 2029, exhibiting a CAGR of 10.10% during the forecast period.
This report provides a deep insight into the global Infectious Diseases Preliminary Screening Tests market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Infectious Diseases Preliminary Screening Tests Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Infectious Diseases Preliminary Screening Tests market in any manner.
Global Infectious Diseases Preliminary Screening Tests Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott
BD
Bio-rad Laboratories, Inc
Cepheid
Hologic Inc
Meridian Bioscience, Inc
OraSure Technologies, Inc
Quidel Corporation
F. Hoffmann-La Roche Ltd
BUREAU VERITAS
Eurofins Scientific
Siemens Healthcare Private Limited
Luminex Corporation
PerkinElmer Inc
QIAGEN
Mesa Biotech
Illumina, Inc
Market Segmentation (by Type)
Over-the-Counter Rapid Test Product
Professional Rapid Test Product
Market Segmentation (by Application)
Infectious Diseases
Hepatitis
Influenza
Malaria
HIV
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Infectious Diseases Preliminary Screening Tests Market
- Overview of the regional outlook of the Infectious Diseases Preliminary Screening Tests Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Infectious Diseases Preliminary Screening Tests Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Infectious Diseases Preliminary Screening Tests
1.2 Key Market Segments
1.2.1 Infectious Diseases Preliminary Screening Tests Segment by Type
1.2.2 Infectious Diseases Preliminary Screening Tests Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFECTIOUS DISEASES PRELIMINARY SCREENING TESTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Infectious Diseases Preliminary Screening Tests Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Infectious Diseases Preliminary Screening Tests Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFECTIOUS DISEASES PRELIMINARY SCREENING TESTS MARKET COMPETITIVE LANDSCAPE
3.1 Global Infectious Diseases Preliminary Screening Tests Sales by Manufacturers (2019-2024)
3.2 Global Infectious Diseases Preliminary Screening Tests Revenue Market Share by Manufacturers (2019-2024)
3.3 Infectious Diseases Preliminary Screening Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Infectious Diseases Preliminary Screening Tests Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Infectious Diseases Preliminary Screening Tests Sales Sites, Area Served, Product Type
3.6 Infectious Diseases Preliminary Screening Tests Market Competitive Situation and Trends
3.6.1 Infectious Diseases Preliminary Screening Tests Market Concentration Rate
3.6.2 Global 5 and 10 Largest Infectious Diseases Preliminary Screening Tests Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASES PRELIMINARY SCREENING TESTS INDUSTRY CHAIN ANALYSIS
4.1 Infectious Diseases Preliminary Screening Tests Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFECTIOUS DISEASES PRELIMINARY SCREENING TESTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INFECTIOUS DISEASES PRELIMINARY SCREENING TESTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Infectious Diseases Preliminary Screening Tests Sales Market Share by Type (2019-2024)
6.3 Global Infectious Diseases Preliminary Screening Tests Market Size Market Share by Type (2019-2024)
6.4 Global Infectious Diseases Preliminary Screening Tests Price by Type (2019-2024)
7 INFECTIOUS DISEASES PRELIMINARY SCREENING TESTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Infectious Diseases Preliminary Screening Tests Market Sales by Application (2019-2024)
7.3 Global Infectious Diseases Preliminary Screening Tests Market Size (M USD) by Application (2019-2024)
7.4 Global Infectious Diseases Preliminary Screening Tests Sales Growth Rate by Application (2019-2024)
8 INFECTIOUS DISEASES PRELIMINARY SCREENING TESTS MARKET SEGMENTATION BY REGION
8.1 Global Infectious Diseases Preliminary Screening Tests Sales by Region
8.1.1 Global Infectious Diseases Preliminary Screening Tests Sales by Region
8.1.2 Global Infectious Diseases Preliminary Screening Tests Sales Market Share by Region
8.2 North America
8.2.1 North America Infectious Diseases Preliminary Screening Tests Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Infectious Diseases Preliminary Screening Tests Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Infectious Diseases Preliminary Screening Tests Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Infectious Diseases Preliminary Screening Tests Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Infectious Diseases Preliminary Screening Tests Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbott
9.1.1 Abbott Infectious Diseases Preliminary Screening Tests Basic Information
9.1.2 Abbott Infectious Diseases Preliminary Screening Tests Product Overview
9.1.3 Abbott Infectious Diseases Preliminary Screening Tests Product Market Performance
9.1.4 Abbott Business Overview
9.1.5 Abbott Infectious Diseases Preliminary Screening Tests SWOT Analysis
9.1.6 Abbott Recent Developments
9.2 BD
9.2.1 BD Infectious Diseases Preliminary Screening Tests Basic Information
9.2.2 BD Infectious Diseases Preliminary Screening Tests Product Overview
9.2.3 BD Infectious Diseases Preliminary Screening Tests Product Market Performance
9.2.4 BD Business Overview
9.2.5 BD Infectious Diseases Preliminary Screening Tests SWOT Analysis
9.2.6 BD Recent Developments
9.3 Bio-rad Laboratories, Inc
9.3.1 Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests Basic Information
9.3.2 Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests Product Overview
9.3.3 Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests Product Market Performance
9.3.4 Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests SWOT Analysis
9.3.5 Bio-rad Laboratories, Inc Business Overview
9.3.6 Bio-rad Laboratories, Inc Recent Developments
9.4 Cepheid
9.4.1 Cepheid Infectious Diseases Preliminary Screening Tests Basic Information
9.4.2 Cepheid Infectious Diseases Preliminary Screening Tests Product Overview
9.4.3 Cepheid Infectious Diseases Preliminary Screening Tests Product Market Performance
9.4.4 Cepheid Business Overview
9.4.5 Cepheid Recent Developments
9.5 Hologic Inc
9.5.1 Hologic Inc Infectious Diseases Preliminary Screening Tests Basic Information
9.5.2 Hologic Inc Infectious Diseases Preliminary Screening Tests Product Overview
9.5.3 Hologic Inc Infectious Diseases Preliminary Screening Tests Product Market Performance
9.5.4 Hologic Inc Business Overview
9.5.5 Hologic Inc Recent Developments
9.6 Meridian Bioscience, Inc
9.6.1 Meridian Bioscience, Inc Infectious Diseases Preliminary Screening Tests Basic Information
9.6.2 Meridian Bioscience, Inc Infectious Diseases Preliminary Screening Tests Product Overview
9.6.3 Meridian Bioscience, Inc Infectious Diseases Preliminary Screening Tests Product Market Performance
9.6.4 Meridian Bioscience, Inc Business Overview
9.6.5 Meridian Bioscience, Inc Recent Developments
9.7 OraSure Technologies, Inc
9.7.1 OraSure Technologies, Inc Infectious Diseases Preliminary Screening Tests Basic Information
9.7.2 OraSure Technologies, Inc Infectious Diseases Preliminary Screening Tests Product Overview
9.7.3 OraSure Technologies, Inc Infectious Diseases Preliminary Screening Tests Product Market Performance
9.7.4 OraSure Technologies, Inc Business Overview
9.7.5 OraSure Technologies, Inc Recent Developments
9.8 Quidel Corporation
9.8.1 Quidel Corporation Infectious Diseases Preliminary Screening Tests Basic Information
9.8.2 Quidel Corporation Infectious Diseases Preliminary Screening Tests Product Overview
9.8.3 Quidel Corporation Infectious Diseases Preliminary Screening Tests Product Market Performance
9.8.4 Quidel Corporation Business Overview
9.8.5 Quidel Corporation Recent Developments
9.9 F. Hoffmann-La Roche Ltd
9.9.1 F. Hoffmann-La Roche Ltd Infectious Diseases Preliminary Screening Tests Basic Information
9.9.2 F. Hoffmann-La Roche Ltd Infectious Diseases Preliminary Screening Tests Product Overview
9.9.3 F. Hoffmann-La Roche Ltd Infectious Diseases Preliminary Screening Tests Product Market Performance
9.9.4 F. Hoffmann-La Roche Ltd Business Overview
9.9.5 F. Hoffmann-La Roche Ltd Recent Developments
9.10 BUREAU VERITAS
9.10.1 BUREAU VERITAS Infectious Diseases Preliminary Screening Tests Basic Information
9.10.2 BUREAU VERITAS Infectious Diseases Preliminary Screening Tests Product Overview
9.10.3 BUREAU VERITAS Infectious Diseases Preliminary Screening Tests Product Market Performance
9.10.4 BUREAU VERITAS Business Overview
9.10.5 BUREAU VERITAS Recent Developments
9.11 Eurofins Scientific
9.11.1 Eurofins Scientific Infectious Diseases Preliminary Screening Tests Basic Information
9.11.2 Eurofins Scientific Infectious Diseases Preliminary Screening Tests Product Overview
9.11.3 Eurofins Scientific Infectious Diseases Preliminary Screening Tests Product Market Performance
9.11.4 Eurofins Scientific Business Overview
9.11.5 Eurofins Scientific Recent Developments
9.12 Siemens Healthcare Private Limited
9.12.1 Siemens Healthcare Private Limited Infectious Diseases Preliminary Screening Tests Basic Information
9.12.2 Siemens Healthcare Private Limited Infectious Diseases Preliminary Screening Tests Product Overview
9.12.3 Siemens Healthcare Private Limited Infectious Diseases Preliminary Screening Tests Product Market Performance
9.12.4 Siemens Healthcare Private Limited Business Overview
9.12.5 Siemens Healthcare Private Limited Recent Developments
9.13 Luminex Corporation
9.13.1 Luminex Corporation Infectious Diseases Preliminary Screening Tests Basic Information
9.13.2 Luminex Corporation Infectious Diseases Preliminary Screening Tests Product Overview
9.13.3 Luminex Corporation Infectious Diseases Preliminary Screening Tests Product Market Performance
9.13.4 Luminex Corporation Business Overview
9.13.5 Luminex Corporation Recent Developments
9.14 PerkinElmer Inc
9.14.1 PerkinElmer Inc Infectious Diseases Preliminary Screening Tests Basic Information
9.14.2 PerkinElmer Inc Infectious Diseases Preliminary Screening Tests Product Overview
9.14.3 PerkinElmer Inc Infectious Diseases Preliminary Screening Tests Product Market Performance
9.14.4 PerkinElmer Inc Business Overview
9.14.5 PerkinElmer Inc Recent Developments
9.15 QIAGEN
9.15.1 QIAGEN Infectious Diseases Preliminary Screening Tests Basic Information
9.15.2 QIAGEN Infectious Diseases Preliminary Screening Tests Product Overview
9.15.3 QIAGEN Infectious Diseases Preliminary Screening Tests Product Market Performance
9.15.4 QIAGEN Business Overview
9.15.5 QIAGEN Recent Developments
9.16 Mesa Biotech
9.16.1 Mesa Biotech Infectious Diseases Preliminary Screening Tests Basic Information
9.16.2 Mesa Biotech Infectious Diseases Preliminary Screening Tests Product Overview
9.16.3 Mesa Biotech Infectious Diseases Preliminary Screening Tests Product Market Performance
9.16.4 Mesa Biotech Business Overview
9.16.5 Mesa Biotech Recent Developments
9.17 Illumina, Inc
9.17.1 Illumina, Inc Infectious Diseases Preliminary Screening Tests Basic Information
9.17.2 Illumina, Inc Infectious Diseases Preliminary Screening Tests Product Overview
9.17.3 Illumina, Inc Infectious Diseases Preliminary Screening Tests Product Market Performance
9.17.4 Illumina, Inc Business Overview
9.17.5 Illumina, Inc Recent Developments
10 INFECTIOUS DISEASES PRELIMINARY SCREENING TESTS MARKET FORECAST BY REGION
10.1 Global Infectious Diseases Preliminary Screening Tests Market Size Forecast
10.2 Global Infectious Diseases Preliminary Screening Tests Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Infectious Diseases Preliminary Screening Tests Market Size Forecast by Country
10.2.3 Asia Pacific Infectious Diseases Preliminary Screening Tests Market Size Forecast by Region
10.2.4 South America Infectious Diseases Preliminary Screening Tests Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Infectious Diseases Preliminary Screening Tests by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Infectious Diseases Preliminary Screening Tests Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Infectious Diseases Preliminary Screening Tests by Type (2025-2030)
11.1.2 Global Infectious Diseases Preliminary Screening Tests Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Infectious Diseases Preliminary Screening Tests by Type (2025-2030)
11.2 Global Infectious Diseases Preliminary Screening Tests Market Forecast by Application (2025-2030)
11.2.1 Global Infectious Diseases Preliminary Screening Tests Sales (K Units) Forecast by Application
11.2.2 Global Infectious Diseases Preliminary Screening Tests Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Infectious Diseases Preliminary Screening Tests
1.2 Key Market Segments
1.2.1 Infectious Diseases Preliminary Screening Tests Segment by Type
1.2.2 Infectious Diseases Preliminary Screening Tests Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFECTIOUS DISEASES PRELIMINARY SCREENING TESTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Infectious Diseases Preliminary Screening Tests Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Infectious Diseases Preliminary Screening Tests Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFECTIOUS DISEASES PRELIMINARY SCREENING TESTS MARKET COMPETITIVE LANDSCAPE
3.1 Global Infectious Diseases Preliminary Screening Tests Sales by Manufacturers (2019-2024)
3.2 Global Infectious Diseases Preliminary Screening Tests Revenue Market Share by Manufacturers (2019-2024)
3.3 Infectious Diseases Preliminary Screening Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Infectious Diseases Preliminary Screening Tests Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Infectious Diseases Preliminary Screening Tests Sales Sites, Area Served, Product Type
3.6 Infectious Diseases Preliminary Screening Tests Market Competitive Situation and Trends
3.6.1 Infectious Diseases Preliminary Screening Tests Market Concentration Rate
3.6.2 Global 5 and 10 Largest Infectious Diseases Preliminary Screening Tests Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASES PRELIMINARY SCREENING TESTS INDUSTRY CHAIN ANALYSIS
4.1 Infectious Diseases Preliminary Screening Tests Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFECTIOUS DISEASES PRELIMINARY SCREENING TESTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INFECTIOUS DISEASES PRELIMINARY SCREENING TESTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Infectious Diseases Preliminary Screening Tests Sales Market Share by Type (2019-2024)
6.3 Global Infectious Diseases Preliminary Screening Tests Market Size Market Share by Type (2019-2024)
6.4 Global Infectious Diseases Preliminary Screening Tests Price by Type (2019-2024)
7 INFECTIOUS DISEASES PRELIMINARY SCREENING TESTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Infectious Diseases Preliminary Screening Tests Market Sales by Application (2019-2024)
7.3 Global Infectious Diseases Preliminary Screening Tests Market Size (M USD) by Application (2019-2024)
7.4 Global Infectious Diseases Preliminary Screening Tests Sales Growth Rate by Application (2019-2024)
8 INFECTIOUS DISEASES PRELIMINARY SCREENING TESTS MARKET SEGMENTATION BY REGION
8.1 Global Infectious Diseases Preliminary Screening Tests Sales by Region
8.1.1 Global Infectious Diseases Preliminary Screening Tests Sales by Region
8.1.2 Global Infectious Diseases Preliminary Screening Tests Sales Market Share by Region
8.2 North America
8.2.1 North America Infectious Diseases Preliminary Screening Tests Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Infectious Diseases Preliminary Screening Tests Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Infectious Diseases Preliminary Screening Tests Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Infectious Diseases Preliminary Screening Tests Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Infectious Diseases Preliminary Screening Tests Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbott
9.1.1 Abbott Infectious Diseases Preliminary Screening Tests Basic Information
9.1.2 Abbott Infectious Diseases Preliminary Screening Tests Product Overview
9.1.3 Abbott Infectious Diseases Preliminary Screening Tests Product Market Performance
9.1.4 Abbott Business Overview
9.1.5 Abbott Infectious Diseases Preliminary Screening Tests SWOT Analysis
9.1.6 Abbott Recent Developments
9.2 BD
9.2.1 BD Infectious Diseases Preliminary Screening Tests Basic Information
9.2.2 BD Infectious Diseases Preliminary Screening Tests Product Overview
9.2.3 BD Infectious Diseases Preliminary Screening Tests Product Market Performance
9.2.4 BD Business Overview
9.2.5 BD Infectious Diseases Preliminary Screening Tests SWOT Analysis
9.2.6 BD Recent Developments
9.3 Bio-rad Laboratories, Inc
9.3.1 Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests Basic Information
9.3.2 Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests Product Overview
9.3.3 Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests Product Market Performance
9.3.4 Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests SWOT Analysis
9.3.5 Bio-rad Laboratories, Inc Business Overview
9.3.6 Bio-rad Laboratories, Inc Recent Developments
9.4 Cepheid
9.4.1 Cepheid Infectious Diseases Preliminary Screening Tests Basic Information
9.4.2 Cepheid Infectious Diseases Preliminary Screening Tests Product Overview
9.4.3 Cepheid Infectious Diseases Preliminary Screening Tests Product Market Performance
9.4.4 Cepheid Business Overview
9.4.5 Cepheid Recent Developments
9.5 Hologic Inc
9.5.1 Hologic Inc Infectious Diseases Preliminary Screening Tests Basic Information
9.5.2 Hologic Inc Infectious Diseases Preliminary Screening Tests Product Overview
9.5.3 Hologic Inc Infectious Diseases Preliminary Screening Tests Product Market Performance
9.5.4 Hologic Inc Business Overview
9.5.5 Hologic Inc Recent Developments
9.6 Meridian Bioscience, Inc
9.6.1 Meridian Bioscience, Inc Infectious Diseases Preliminary Screening Tests Basic Information
9.6.2 Meridian Bioscience, Inc Infectious Diseases Preliminary Screening Tests Product Overview
9.6.3 Meridian Bioscience, Inc Infectious Diseases Preliminary Screening Tests Product Market Performance
9.6.4 Meridian Bioscience, Inc Business Overview
9.6.5 Meridian Bioscience, Inc Recent Developments
9.7 OraSure Technologies, Inc
9.7.1 OraSure Technologies, Inc Infectious Diseases Preliminary Screening Tests Basic Information
9.7.2 OraSure Technologies, Inc Infectious Diseases Preliminary Screening Tests Product Overview
9.7.3 OraSure Technologies, Inc Infectious Diseases Preliminary Screening Tests Product Market Performance
9.7.4 OraSure Technologies, Inc Business Overview
9.7.5 OraSure Technologies, Inc Recent Developments
9.8 Quidel Corporation
9.8.1 Quidel Corporation Infectious Diseases Preliminary Screening Tests Basic Information
9.8.2 Quidel Corporation Infectious Diseases Preliminary Screening Tests Product Overview
9.8.3 Quidel Corporation Infectious Diseases Preliminary Screening Tests Product Market Performance
9.8.4 Quidel Corporation Business Overview
9.8.5 Quidel Corporation Recent Developments
9.9 F. Hoffmann-La Roche Ltd
9.9.1 F. Hoffmann-La Roche Ltd Infectious Diseases Preliminary Screening Tests Basic Information
9.9.2 F. Hoffmann-La Roche Ltd Infectious Diseases Preliminary Screening Tests Product Overview
9.9.3 F. Hoffmann-La Roche Ltd Infectious Diseases Preliminary Screening Tests Product Market Performance
9.9.4 F. Hoffmann-La Roche Ltd Business Overview
9.9.5 F. Hoffmann-La Roche Ltd Recent Developments
9.10 BUREAU VERITAS
9.10.1 BUREAU VERITAS Infectious Diseases Preliminary Screening Tests Basic Information
9.10.2 BUREAU VERITAS Infectious Diseases Preliminary Screening Tests Product Overview
9.10.3 BUREAU VERITAS Infectious Diseases Preliminary Screening Tests Product Market Performance
9.10.4 BUREAU VERITAS Business Overview
9.10.5 BUREAU VERITAS Recent Developments
9.11 Eurofins Scientific
9.11.1 Eurofins Scientific Infectious Diseases Preliminary Screening Tests Basic Information
9.11.2 Eurofins Scientific Infectious Diseases Preliminary Screening Tests Product Overview
9.11.3 Eurofins Scientific Infectious Diseases Preliminary Screening Tests Product Market Performance
9.11.4 Eurofins Scientific Business Overview
9.11.5 Eurofins Scientific Recent Developments
9.12 Siemens Healthcare Private Limited
9.12.1 Siemens Healthcare Private Limited Infectious Diseases Preliminary Screening Tests Basic Information
9.12.2 Siemens Healthcare Private Limited Infectious Diseases Preliminary Screening Tests Product Overview
9.12.3 Siemens Healthcare Private Limited Infectious Diseases Preliminary Screening Tests Product Market Performance
9.12.4 Siemens Healthcare Private Limited Business Overview
9.12.5 Siemens Healthcare Private Limited Recent Developments
9.13 Luminex Corporation
9.13.1 Luminex Corporation Infectious Diseases Preliminary Screening Tests Basic Information
9.13.2 Luminex Corporation Infectious Diseases Preliminary Screening Tests Product Overview
9.13.3 Luminex Corporation Infectious Diseases Preliminary Screening Tests Product Market Performance
9.13.4 Luminex Corporation Business Overview
9.13.5 Luminex Corporation Recent Developments
9.14 PerkinElmer Inc
9.14.1 PerkinElmer Inc Infectious Diseases Preliminary Screening Tests Basic Information
9.14.2 PerkinElmer Inc Infectious Diseases Preliminary Screening Tests Product Overview
9.14.3 PerkinElmer Inc Infectious Diseases Preliminary Screening Tests Product Market Performance
9.14.4 PerkinElmer Inc Business Overview
9.14.5 PerkinElmer Inc Recent Developments
9.15 QIAGEN
9.15.1 QIAGEN Infectious Diseases Preliminary Screening Tests Basic Information
9.15.2 QIAGEN Infectious Diseases Preliminary Screening Tests Product Overview
9.15.3 QIAGEN Infectious Diseases Preliminary Screening Tests Product Market Performance
9.15.4 QIAGEN Business Overview
9.15.5 QIAGEN Recent Developments
9.16 Mesa Biotech
9.16.1 Mesa Biotech Infectious Diseases Preliminary Screening Tests Basic Information
9.16.2 Mesa Biotech Infectious Diseases Preliminary Screening Tests Product Overview
9.16.3 Mesa Biotech Infectious Diseases Preliminary Screening Tests Product Market Performance
9.16.4 Mesa Biotech Business Overview
9.16.5 Mesa Biotech Recent Developments
9.17 Illumina, Inc
9.17.1 Illumina, Inc Infectious Diseases Preliminary Screening Tests Basic Information
9.17.2 Illumina, Inc Infectious Diseases Preliminary Screening Tests Product Overview
9.17.3 Illumina, Inc Infectious Diseases Preliminary Screening Tests Product Market Performance
9.17.4 Illumina, Inc Business Overview
9.17.5 Illumina, Inc Recent Developments
10 INFECTIOUS DISEASES PRELIMINARY SCREENING TESTS MARKET FORECAST BY REGION
10.1 Global Infectious Diseases Preliminary Screening Tests Market Size Forecast
10.2 Global Infectious Diseases Preliminary Screening Tests Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Infectious Diseases Preliminary Screening Tests Market Size Forecast by Country
10.2.3 Asia Pacific Infectious Diseases Preliminary Screening Tests Market Size Forecast by Region
10.2.4 South America Infectious Diseases Preliminary Screening Tests Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Infectious Diseases Preliminary Screening Tests by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Infectious Diseases Preliminary Screening Tests Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Infectious Diseases Preliminary Screening Tests by Type (2025-2030)
11.1.2 Global Infectious Diseases Preliminary Screening Tests Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Infectious Diseases Preliminary Screening Tests by Type (2025-2030)
11.2 Global Infectious Diseases Preliminary Screening Tests Market Forecast by Application (2025-2030)
11.2.1 Global Infectious Diseases Preliminary Screening Tests Sales (K Units) Forecast by Application
11.2.2 Global Infectious Diseases Preliminary Screening Tests Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Infectious Diseases Preliminary Screening Tests Market Size Comparison by Region (M USD)
Table 5. Global Infectious Diseases Preliminary Screening Tests Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Infectious Diseases Preliminary Screening Tests Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Infectious Diseases Preliminary Screening Tests Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Infectious Diseases Preliminary Screening Tests Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases Preliminary Screening Tests as of 2022)
Table 10. Global Market Infectious Diseases Preliminary Screening Tests Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Infectious Diseases Preliminary Screening Tests Sales Sites and Area Served
Table 12. Manufacturers Infectious Diseases Preliminary Screening Tests Product Type
Table 13. Global Infectious Diseases Preliminary Screening Tests Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Infectious Diseases Preliminary Screening Tests
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Infectious Diseases Preliminary Screening Tests Market Challenges
Table 22. Global Infectious Diseases Preliminary Screening Tests Sales by Type (K Units)
Table 23. Global Infectious Diseases Preliminary Screening Tests Market Size by Type (M USD)
Table 24. Global Infectious Diseases Preliminary Screening Tests Sales (K Units) by Type (2019-2024)
Table 25. Global Infectious Diseases Preliminary Screening Tests Sales Market Share by Type (2019-2024)
Table 26. Global Infectious Diseases Preliminary Screening Tests Market Size (M USD) by Type (2019-2024)
Table 27. Global Infectious Diseases Preliminary Screening Tests Market Size Share by Type (2019-2024)
Table 28. Global Infectious Diseases Preliminary Screening Tests Price (USD/Unit) by Type (2019-2024)
Table 29. Global Infectious Diseases Preliminary Screening Tests Sales (K Units) by Application
Table 30. Global Infectious Diseases Preliminary Screening Tests Market Size by Application
Table 31. Global Infectious Diseases Preliminary Screening Tests Sales by Application (2019-2024) & (K Units)
Table 32. Global Infectious Diseases Preliminary Screening Tests Sales Market Share by Application (2019-2024)
Table 33. Global Infectious Diseases Preliminary Screening Tests Sales by Application (2019-2024) & (M USD)
Table 34. Global Infectious Diseases Preliminary Screening Tests Market Share by Application (2019-2024)
Table 35. Global Infectious Diseases Preliminary Screening Tests Sales Growth Rate by Application (2019-2024)
Table 36. Global Infectious Diseases Preliminary Screening Tests Sales by Region (2019-2024) & (K Units)
Table 37. Global Infectious Diseases Preliminary Screening Tests Sales Market Share by Region (2019-2024)
Table 38. North America Infectious Diseases Preliminary Screening Tests Sales by Country (2019-2024) & (K Units)
Table 39. Europe Infectious Diseases Preliminary Screening Tests Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Infectious Diseases Preliminary Screening Tests Sales by Region (2019-2024) & (K Units)
Table 41. South America Infectious Diseases Preliminary Screening Tests Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Infectious Diseases Preliminary Screening Tests Sales by Region (2019-2024) & (K Units)
Table 43. Abbott Infectious Diseases Preliminary Screening Tests Basic Information
Table 44. Abbott Infectious Diseases Preliminary Screening Tests Product Overview
Table 45. Abbott Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abbott Business Overview
Table 47. Abbott Infectious Diseases Preliminary Screening Tests SWOT Analysis
Table 48. Abbott Recent Developments
Table 49. BD Infectious Diseases Preliminary Screening Tests Basic Information
Table 50. BD Infectious Diseases Preliminary Screening Tests Product Overview
Table 51. BD Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. BD Business Overview
Table 53. BD Infectious Diseases Preliminary Screening Tests SWOT Analysis
Table 54. BD Recent Developments
Table 55. Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests Basic Information
Table 56. Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests Product Overview
Table 57. Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests SWOT Analysis
Table 59. Bio-rad Laboratories, Inc Business Overview
Table 60. Bio-rad Laboratories, Inc Recent Developments
Table 61. Cepheid Infectious Diseases Preliminary Screening Tests Basic Information
Table 62. Cepheid Infectious Diseases Preliminary Screening Tests Product Overview
Table 63. Cepheid Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Cepheid Business Overview
Table 65. Cepheid Recent Developments
Table 66. Hologic Inc Infectious Diseases Preliminary Screening Tests Basic Information
Table 67. Hologic Inc Infectious Diseases Preliminary Screening Tests Product Overview
Table 68. Hologic Inc Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Hologic Inc Business Overview
Table 70. Hologic Inc Recent Developments
Table 71. Meridian Bioscience, Inc Infectious Diseases Preliminary Screening Tests Basic Information
Table 72. Meridian Bioscience, Inc Infectious Diseases Preliminary Screening Tests Product Overview
Table 73. Meridian Bioscience, Inc Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Meridian Bioscience, Inc Business Overview
Table 75. Meridian Bioscience, Inc Recent Developments
Table 76. OraSure Technologies, Inc Infectious Diseases Preliminary Screening Tests Basic Information
Table 77. OraSure Technologies, Inc Infectious Diseases Preliminary Screening Tests Product Overview
Table 78. OraSure Technologies, Inc Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. OraSure Technologies, Inc Business Overview
Table 80. OraSure Technologies, Inc Recent Developments
Table 81. Quidel Corporation Infectious Diseases Preliminary Screening Tests Basic Information
Table 82. Quidel Corporation Infectious Diseases Preliminary Screening Tests Product Overview
Table 83. Quidel Corporation Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Quidel Corporation Business Overview
Table 85. Quidel Corporation Recent Developments
Table 86. F. Hoffmann-La Roche Ltd Infectious Diseases Preliminary Screening Tests Basic Information
Table 87. F. Hoffmann-La Roche Ltd Infectious Diseases Preliminary Screening Tests Product Overview
Table 88. F. Hoffmann-La Roche Ltd Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. F. Hoffmann-La Roche Ltd Business Overview
Table 90. F. Hoffmann-La Roche Ltd Recent Developments
Table 91. BUREAU VERITAS Infectious Diseases Preliminary Screening Tests Basic Information
Table 92. BUREAU VERITAS Infectious Diseases Preliminary Screening Tests Product Overview
Table 93. BUREAU VERITAS Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. BUREAU VERITAS Business Overview
Table 95. BUREAU VERITAS Recent Developments
Table 96. Eurofins Scientific Infectious Diseases Preliminary Screening Tests Basic Information
Table 97. Eurofins Scientific Infectious Diseases Preliminary Screening Tests Product Overview
Table 98. Eurofins Scientific Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Eurofins Scientific Business Overview
Table 100. Eurofins Scientific Recent Developments
Table 101. Siemens Healthcare Private Limited Infectious Diseases Preliminary Screening Tests Basic Information
Table 102. Siemens Healthcare Private Limited Infectious Diseases Preliminary Screening Tests Product Overview
Table 103. Siemens Healthcare Private Limited Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Siemens Healthcare Private Limited Business Overview
Table 105. Siemens Healthcare Private Limited Recent Developments
Table 106. Luminex Corporation Infectious Diseases Preliminary Screening Tests Basic Information
Table 107. Luminex Corporation Infectious Diseases Preliminary Screening Tests Product Overview
Table 108. Luminex Corporation Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Luminex Corporation Business Overview
Table 110. Luminex Corporation Recent Developments
Table 111. PerkinElmer Inc Infectious Diseases Preliminary Screening Tests Basic Information
Table 112. PerkinElmer Inc Infectious Diseases Preliminary Screening Tests Product Overview
Table 113. PerkinElmer Inc Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. PerkinElmer Inc Business Overview
Table 115. PerkinElmer Inc Recent Developments
Table 116. QIAGEN Infectious Diseases Preliminary Screening Tests Basic Information
Table 117. QIAGEN Infectious Diseases Preliminary Screening Tests Product Overview
Table 118. QIAGEN Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. QIAGEN Business Overview
Table 120. QIAGEN Recent Developments
Table 121. Mesa Biotech Infectious Diseases Preliminary Screening Tests Basic Information
Table 122. Mesa Biotech Infectious Diseases Preliminary Screening Tests Product Overview
Table 123. Mesa Biotech Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Mesa Biotech Business Overview
Table 125. Mesa Biotech Recent Developments
Table 126. Illumina, Inc Infectious Diseases Preliminary Screening Tests Basic Information
Table 127. Illumina, Inc Infectious Diseases Preliminary Screening Tests Product Overview
Table 128. Illumina, Inc Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Illumina, Inc Business Overview
Table 130. Illumina, Inc Recent Developments
Table 131. Global Infectious Diseases Preliminary Screening Tests Sales Forecast by Region (2025-2030) & (K Units)
Table 132. Global Infectious Diseases Preliminary Screening Tests Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America Infectious Diseases Preliminary Screening Tests Sales Forecast by Country (2025-2030) & (K Units)
Table 134. North America Infectious Diseases Preliminary Screening Tests Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe Infectious Diseases Preliminary Screening Tests Sales Forecast by Country (2025-2030) & (K Units)
Table 136. Europe Infectious Diseases Preliminary Screening Tests Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific Infectious Diseases Preliminary Screening Tests Sales Forecast by Region (2025-2030) & (K Units)
Table 138. Asia Pacific Infectious Diseases Preliminary Screening Tests Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America Infectious Diseases Preliminary Screening Tests Sales Forecast by Country (2025-2030) & (K Units)
Table 140. South America Infectious Diseases Preliminary Screening Tests Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa Infectious Diseases Preliminary Screening Tests Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa Infectious Diseases Preliminary Screening Tests Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global Infectious Diseases Preliminary Screening Tests Sales Forecast by Type (2025-2030) & (K Units)
Table 144. Global Infectious Diseases Preliminary Screening Tests Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global Infectious Diseases Preliminary Screening Tests Price Forecast by Type (2025-2030) & (USD/Unit)
Table 146. Global Infectious Diseases Preliminary Screening Tests Sales (K Units) Forecast by Application (2025-2030)
Table 147. Global Infectious Diseases Preliminary Screening Tests Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Infectious Diseases Preliminary Screening Tests Market Size Comparison by Region (M USD)
Table 5. Global Infectious Diseases Preliminary Screening Tests Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Infectious Diseases Preliminary Screening Tests Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Infectious Diseases Preliminary Screening Tests Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Infectious Diseases Preliminary Screening Tests Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases Preliminary Screening Tests as of 2022)
Table 10. Global Market Infectious Diseases Preliminary Screening Tests Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Infectious Diseases Preliminary Screening Tests Sales Sites and Area Served
Table 12. Manufacturers Infectious Diseases Preliminary Screening Tests Product Type
Table 13. Global Infectious Diseases Preliminary Screening Tests Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Infectious Diseases Preliminary Screening Tests
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Infectious Diseases Preliminary Screening Tests Market Challenges
Table 22. Global Infectious Diseases Preliminary Screening Tests Sales by Type (K Units)
Table 23. Global Infectious Diseases Preliminary Screening Tests Market Size by Type (M USD)
Table 24. Global Infectious Diseases Preliminary Screening Tests Sales (K Units) by Type (2019-2024)
Table 25. Global Infectious Diseases Preliminary Screening Tests Sales Market Share by Type (2019-2024)
Table 26. Global Infectious Diseases Preliminary Screening Tests Market Size (M USD) by Type (2019-2024)
Table 27. Global Infectious Diseases Preliminary Screening Tests Market Size Share by Type (2019-2024)
Table 28. Global Infectious Diseases Preliminary Screening Tests Price (USD/Unit) by Type (2019-2024)
Table 29. Global Infectious Diseases Preliminary Screening Tests Sales (K Units) by Application
Table 30. Global Infectious Diseases Preliminary Screening Tests Market Size by Application
Table 31. Global Infectious Diseases Preliminary Screening Tests Sales by Application (2019-2024) & (K Units)
Table 32. Global Infectious Diseases Preliminary Screening Tests Sales Market Share by Application (2019-2024)
Table 33. Global Infectious Diseases Preliminary Screening Tests Sales by Application (2019-2024) & (M USD)
Table 34. Global Infectious Diseases Preliminary Screening Tests Market Share by Application (2019-2024)
Table 35. Global Infectious Diseases Preliminary Screening Tests Sales Growth Rate by Application (2019-2024)
Table 36. Global Infectious Diseases Preliminary Screening Tests Sales by Region (2019-2024) & (K Units)
Table 37. Global Infectious Diseases Preliminary Screening Tests Sales Market Share by Region (2019-2024)
Table 38. North America Infectious Diseases Preliminary Screening Tests Sales by Country (2019-2024) & (K Units)
Table 39. Europe Infectious Diseases Preliminary Screening Tests Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Infectious Diseases Preliminary Screening Tests Sales by Region (2019-2024) & (K Units)
Table 41. South America Infectious Diseases Preliminary Screening Tests Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Infectious Diseases Preliminary Screening Tests Sales by Region (2019-2024) & (K Units)
Table 43. Abbott Infectious Diseases Preliminary Screening Tests Basic Information
Table 44. Abbott Infectious Diseases Preliminary Screening Tests Product Overview
Table 45. Abbott Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abbott Business Overview
Table 47. Abbott Infectious Diseases Preliminary Screening Tests SWOT Analysis
Table 48. Abbott Recent Developments
Table 49. BD Infectious Diseases Preliminary Screening Tests Basic Information
Table 50. BD Infectious Diseases Preliminary Screening Tests Product Overview
Table 51. BD Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. BD Business Overview
Table 53. BD Infectious Diseases Preliminary Screening Tests SWOT Analysis
Table 54. BD Recent Developments
Table 55. Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests Basic Information
Table 56. Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests Product Overview
Table 57. Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests SWOT Analysis
Table 59. Bio-rad Laboratories, Inc Business Overview
Table 60. Bio-rad Laboratories, Inc Recent Developments
Table 61. Cepheid Infectious Diseases Preliminary Screening Tests Basic Information
Table 62. Cepheid Infectious Diseases Preliminary Screening Tests Product Overview
Table 63. Cepheid Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Cepheid Business Overview
Table 65. Cepheid Recent Developments
Table 66. Hologic Inc Infectious Diseases Preliminary Screening Tests Basic Information
Table 67. Hologic Inc Infectious Diseases Preliminary Screening Tests Product Overview
Table 68. Hologic Inc Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Hologic Inc Business Overview
Table 70. Hologic Inc Recent Developments
Table 71. Meridian Bioscience, Inc Infectious Diseases Preliminary Screening Tests Basic Information
Table 72. Meridian Bioscience, Inc Infectious Diseases Preliminary Screening Tests Product Overview
Table 73. Meridian Bioscience, Inc Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Meridian Bioscience, Inc Business Overview
Table 75. Meridian Bioscience, Inc Recent Developments
Table 76. OraSure Technologies, Inc Infectious Diseases Preliminary Screening Tests Basic Information
Table 77. OraSure Technologies, Inc Infectious Diseases Preliminary Screening Tests Product Overview
Table 78. OraSure Technologies, Inc Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. OraSure Technologies, Inc Business Overview
Table 80. OraSure Technologies, Inc Recent Developments
Table 81. Quidel Corporation Infectious Diseases Preliminary Screening Tests Basic Information
Table 82. Quidel Corporation Infectious Diseases Preliminary Screening Tests Product Overview
Table 83. Quidel Corporation Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Quidel Corporation Business Overview
Table 85. Quidel Corporation Recent Developments
Table 86. F. Hoffmann-La Roche Ltd Infectious Diseases Preliminary Screening Tests Basic Information
Table 87. F. Hoffmann-La Roche Ltd Infectious Diseases Preliminary Screening Tests Product Overview
Table 88. F. Hoffmann-La Roche Ltd Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. F. Hoffmann-La Roche Ltd Business Overview
Table 90. F. Hoffmann-La Roche Ltd Recent Developments
Table 91. BUREAU VERITAS Infectious Diseases Preliminary Screening Tests Basic Information
Table 92. BUREAU VERITAS Infectious Diseases Preliminary Screening Tests Product Overview
Table 93. BUREAU VERITAS Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. BUREAU VERITAS Business Overview
Table 95. BUREAU VERITAS Recent Developments
Table 96. Eurofins Scientific Infectious Diseases Preliminary Screening Tests Basic Information
Table 97. Eurofins Scientific Infectious Diseases Preliminary Screening Tests Product Overview
Table 98. Eurofins Scientific Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Eurofins Scientific Business Overview
Table 100. Eurofins Scientific Recent Developments
Table 101. Siemens Healthcare Private Limited Infectious Diseases Preliminary Screening Tests Basic Information
Table 102. Siemens Healthcare Private Limited Infectious Diseases Preliminary Screening Tests Product Overview
Table 103. Siemens Healthcare Private Limited Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Siemens Healthcare Private Limited Business Overview
Table 105. Siemens Healthcare Private Limited Recent Developments
Table 106. Luminex Corporation Infectious Diseases Preliminary Screening Tests Basic Information
Table 107. Luminex Corporation Infectious Diseases Preliminary Screening Tests Product Overview
Table 108. Luminex Corporation Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Luminex Corporation Business Overview
Table 110. Luminex Corporation Recent Developments
Table 111. PerkinElmer Inc Infectious Diseases Preliminary Screening Tests Basic Information
Table 112. PerkinElmer Inc Infectious Diseases Preliminary Screening Tests Product Overview
Table 113. PerkinElmer Inc Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. PerkinElmer Inc Business Overview
Table 115. PerkinElmer Inc Recent Developments
Table 116. QIAGEN Infectious Diseases Preliminary Screening Tests Basic Information
Table 117. QIAGEN Infectious Diseases Preliminary Screening Tests Product Overview
Table 118. QIAGEN Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. QIAGEN Business Overview
Table 120. QIAGEN Recent Developments
Table 121. Mesa Biotech Infectious Diseases Preliminary Screening Tests Basic Information
Table 122. Mesa Biotech Infectious Diseases Preliminary Screening Tests Product Overview
Table 123. Mesa Biotech Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Mesa Biotech Business Overview
Table 125. Mesa Biotech Recent Developments
Table 126. Illumina, Inc Infectious Diseases Preliminary Screening Tests Basic Information
Table 127. Illumina, Inc Infectious Diseases Preliminary Screening Tests Product Overview
Table 128. Illumina, Inc Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Illumina, Inc Business Overview
Table 130. Illumina, Inc Recent Developments
Table 131. Global Infectious Diseases Preliminary Screening Tests Sales Forecast by Region (2025-2030) & (K Units)
Table 132. Global Infectious Diseases Preliminary Screening Tests Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America Infectious Diseases Preliminary Screening Tests Sales Forecast by Country (2025-2030) & (K Units)
Table 134. North America Infectious Diseases Preliminary Screening Tests Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe Infectious Diseases Preliminary Screening Tests Sales Forecast by Country (2025-2030) & (K Units)
Table 136. Europe Infectious Diseases Preliminary Screening Tests Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific Infectious Diseases Preliminary Screening Tests Sales Forecast by Region (2025-2030) & (K Units)
Table 138. Asia Pacific Infectious Diseases Preliminary Screening Tests Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America Infectious Diseases Preliminary Screening Tests Sales Forecast by Country (2025-2030) & (K Units)
Table 140. South America Infectious Diseases Preliminary Screening Tests Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa Infectious Diseases Preliminary Screening Tests Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa Infectious Diseases Preliminary Screening Tests Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global Infectious Diseases Preliminary Screening Tests Sales Forecast by Type (2025-2030) & (K Units)
Table 144. Global Infectious Diseases Preliminary Screening Tests Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global Infectious Diseases Preliminary Screening Tests Price Forecast by Type (2025-2030) & (USD/Unit)
Table 146. Global Infectious Diseases Preliminary Screening Tests Sales (K Units) Forecast by Application (2025-2030)
Table 147. Global Infectious Diseases Preliminary Screening Tests Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Infectious Diseases Preliminary Screening Tests
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Infectious Diseases Preliminary Screening Tests Market Size (M USD), 2019-2030
Figure 5. Global Infectious Diseases Preliminary Screening Tests Market Size (M USD) (2019-2030)
Figure 6. Global Infectious Diseases Preliminary Screening Tests Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Infectious Diseases Preliminary Screening Tests Market Size by Country (M USD)
Figure 11. Infectious Diseases Preliminary Screening Tests Sales Share by Manufacturers in 2023
Figure 12. Global Infectious Diseases Preliminary Screening Tests Revenue Share by Manufacturers in 2023
Figure 13. Infectious Diseases Preliminary Screening Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Infectious Diseases Preliminary Screening Tests Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Infectious Diseases Preliminary Screening Tests Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Infectious Diseases Preliminary Screening Tests Market Share by Type
Figure 18. Sales Market Share of Infectious Diseases Preliminary Screening Tests by Type (2019-2024)
Figure 19. Sales Market Share of Infectious Diseases Preliminary Screening Tests by Type in 2023
Figure 20. Market Size Share of Infectious Diseases Preliminary Screening Tests by Type (2019-2024)
Figure 21. Market Size Market Share of Infectious Diseases Preliminary Screening Tests by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Infectious Diseases Preliminary Screening Tests Market Share by Application
Figure 24. Global Infectious Diseases Preliminary Screening Tests Sales Market Share by Application (2019-2024)
Figure 25. Global Infectious Diseases Preliminary Screening Tests Sales Market Share by Application in 2023
Figure 26. Global Infectious Diseases Preliminary Screening Tests Market Share by Application (2019-2024)
Figure 27. Global Infectious Diseases Preliminary Screening Tests Market Share by Application in 2023
Figure 28. Global Infectious Diseases Preliminary Screening Tests Sales Growth Rate by Application (2019-2024)
Figure 29. Global Infectious Diseases Preliminary Screening Tests Sales Market Share by Region (2019-2024)
Figure 30. North America Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Infectious Diseases Preliminary Screening Tests Sales Market Share by Country in 2023
Figure 32. U.S. Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Infectious Diseases Preliminary Screening Tests Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Infectious Diseases Preliminary Screening Tests Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Infectious Diseases Preliminary Screening Tests Sales Market Share by Country in 2023
Figure 37. Germany Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Infectious Diseases Preliminary Screening Tests Sales Market Share by Region in 2023
Figure 44. China Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (K Units)
Figure 50. South America Infectious Diseases Preliminary Screening Tests Sales Market Share by Country in 2023
Figure 51. Brazil Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Infectious Diseases Preliminary Screening Tests Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Infectious Diseases Preliminary Screening Tests Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Infectious Diseases Preliminary Screening Tests Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Infectious Diseases Preliminary Screening Tests Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Infectious Diseases Preliminary Screening Tests Market Share Forecast by Type (2025-2030)
Figure 65. Global Infectious Diseases Preliminary Screening Tests Sales Forecast by Application (2025-2030)
Figure 66. Global Infectious Diseases Preliminary Screening Tests Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Infectious Diseases Preliminary Screening Tests
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Infectious Diseases Preliminary Screening Tests Market Size (M USD), 2019-2030
Figure 5. Global Infectious Diseases Preliminary Screening Tests Market Size (M USD) (2019-2030)
Figure 6. Global Infectious Diseases Preliminary Screening Tests Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Infectious Diseases Preliminary Screening Tests Market Size by Country (M USD)
Figure 11. Infectious Diseases Preliminary Screening Tests Sales Share by Manufacturers in 2023
Figure 12. Global Infectious Diseases Preliminary Screening Tests Revenue Share by Manufacturers in 2023
Figure 13. Infectious Diseases Preliminary Screening Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Infectious Diseases Preliminary Screening Tests Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Infectious Diseases Preliminary Screening Tests Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Infectious Diseases Preliminary Screening Tests Market Share by Type
Figure 18. Sales Market Share of Infectious Diseases Preliminary Screening Tests by Type (2019-2024)
Figure 19. Sales Market Share of Infectious Diseases Preliminary Screening Tests by Type in 2023
Figure 20. Market Size Share of Infectious Diseases Preliminary Screening Tests by Type (2019-2024)
Figure 21. Market Size Market Share of Infectious Diseases Preliminary Screening Tests by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Infectious Diseases Preliminary Screening Tests Market Share by Application
Figure 24. Global Infectious Diseases Preliminary Screening Tests Sales Market Share by Application (2019-2024)
Figure 25. Global Infectious Diseases Preliminary Screening Tests Sales Market Share by Application in 2023
Figure 26. Global Infectious Diseases Preliminary Screening Tests Market Share by Application (2019-2024)
Figure 27. Global Infectious Diseases Preliminary Screening Tests Market Share by Application in 2023
Figure 28. Global Infectious Diseases Preliminary Screening Tests Sales Growth Rate by Application (2019-2024)
Figure 29. Global Infectious Diseases Preliminary Screening Tests Sales Market Share by Region (2019-2024)
Figure 30. North America Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Infectious Diseases Preliminary Screening Tests Sales Market Share by Country in 2023
Figure 32. U.S. Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Infectious Diseases Preliminary Screening Tests Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Infectious Diseases Preliminary Screening Tests Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Infectious Diseases Preliminary Screening Tests Sales Market Share by Country in 2023
Figure 37. Germany Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Infectious Diseases Preliminary Screening Tests Sales Market Share by Region in 2023
Figure 44. China Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (K Units)
Figure 50. South America Infectious Diseases Preliminary Screening Tests Sales Market Share by Country in 2023
Figure 51. Brazil Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Infectious Diseases Preliminary Screening Tests Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Infectious Diseases Preliminary Screening Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Infectious Diseases Preliminary Screening Tests Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Infectious Diseases Preliminary Screening Tests Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Infectious Diseases Preliminary Screening Tests Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Infectious Diseases Preliminary Screening Tests Market Share Forecast by Type (2025-2030)
Figure 65. Global Infectious Diseases Preliminary Screening Tests Sales Forecast by Application (2025-2030)
Figure 66. Global Infectious Diseases Preliminary Screening Tests Market Share Forecast by Application (2025-2030)
